Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Human Tinea Pedis Drugs Market by Type (Cream, Spray, Others), By Application (Offline Store, Online Store) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Human Tinea Pedis Drugs Market by Type (Cream, Spray, Others), By Application (Offline Store, Online Store) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 346314 4200 Pharma & Healthcare 377 211 Pages 4.9 (32)
                                          

Market Overview:


The global human tinea pedis drugs market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of tinea pedis, rising awareness about available treatment options, and growing demand for topical antifungal drugs. The global human tinea pedis drugs market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into creams, sprays, and others. The creams segment is expected to account for a major share of the global human tinea pedis drugs market in 2018 owing to their high efficacy and ease of use. On the basis of application, the market is divided into offline store and online store segments. The offline store segment accounted for a major share of the global human tinea pedis drugs market in 2017 due to higher adoption rates in developing countries.


Global Human Tinea Pedis Drugs Industry Outlook


Product Definition:


Human Tinea Pedis Drugs is a drug used to treat tinea pedis, a fungal infection of the feet. It is important because it can help clear up the infection and prevent it from spreading.


Cream:


Cream is a topical anti-fungal medication used for the treatment of athlete's foot, ringworm, and jock itch. It works by killing the fungi that causes infection. Creams are available in various forms such as creams, lotions, gels and sprays.


Spray:


Spray is a topical solution that is applied to the skin for treating foot and ankle-related infections. It helps in reducing pain, itching, and inflammation of the skin as well as improves blood circulation in feet. The active ingredient present in spray helps to fight against fungi, bacteria, and viruses that cause tinea pedis (foot-related infection).


Application Insights:


The offline store was the dominant application segment in the global human tinea pedis drugs market, accounting for over 70% of the revenue share in 2017. TheOffline store is a retail establishment that stocks medicines and medical supplies. This type of store caters to people who cannot travel far from their homes due to physical disability or illness. These stores are present near hospitals and clinics where patients get access to various types of foot care treatments including medication, surgeries, diagnosis & treatment services for human tinea pedis at a reasonable cost as compared to other costs incurred while getting these services done at clinics or hospitals.


Online stores on the other hand cater more towards convenience than accessibility; customers living in remote areas with no presence of offline drugstores can easily order medicine through online stores owing to their 24*7 availability throughout the year along with easy payment options such as net banking.


Regional Analysis:


North America dominated the global human tinea pedis drugs market in 2017. The presence of key players, favorable reimbursement policies, and high adoption rate for new treatment options are some factors responsible for its large share. In addition, increasing prevalence of nail disorders is also expected to drive growth during the forecast period. For instance, according to a study published in JAMA Dermatology by American Academy of Dermatology (AAD), around 50 million people suffer from fungal infections each year in U.S.


Asia Pacific is estimated to be fastest growing region during the forecast period owing to rising disposable income coupled with growing awareness about early diagnosis among patients especially in developing countries such as India and China; hence driving demand for effective treatment methods leading towards growth opportunity for human tineae-pedis drugs market players over this region.


Growth Factors:


  • Increasing incidence of tinea pedis owing to changing lifestyle and increasing population base.
  • Growing awareness about the treatment and diagnosis of tinea pedis among people, especially in the developed countries.
  • Rising demand for better-tolerated and more efficacious drugs for the treatment of tinea pedis, which is expected to drive market growth during the forecast period.
  • Technological advancements in drug delivery systems that would offer more targeted therapies for tinea pedis are likely to propel market growth over the forecast period.

Scope Of The Report

Report Attributes

Report Details

Report Title

Human Tinea Pedis Drugs Market Research Report

By Type

Cream, Spray, Others

By Application

Offline Store, Online Store

By Companies

Bayer, GSK, Johnson & Johnson, Novartis, Bausch Health, TEVA, Taro Pharmaceutical, WellSpring Pharma, Crown Laboratories, Medimetriks Pharmaceuticals

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

211

Number of Tables & Figures

148

Customization Available

Yes, the report can be customized as per your need.


Global Human Tinea Pedis Drugs Market Report Segments:

The global Human Tinea Pedis Drugs market is segmented on the basis of:

Types

Cream, Spray, Others

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Offline Store, Online Store

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Bayer
  2. GSK
  3. Johnson & Johnson
  4. Novartis
  5. Bausch Health
  6. TEVA
  7. Taro Pharmaceutical
  8. WellSpring Pharma
  9. Crown Laboratories
  10. Medimetriks Pharmaceuticals

Global Human Tinea Pedis Drugs Market Overview


Highlights of The Human Tinea Pedis Drugs Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Cream
    2. Spray
    3. Others
  1. By Application:

    1. Offline Store
    2. Online Store
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Human Tinea Pedis Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Human Tinea Pedis Drugs Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


There are a number of drugs used to treat human tinea pedis. These include topical creams, oral medications, and systemic antibiotics.

Some of the major companies in the human tinea pedis drugs market are Bayer, GSK, Johnson & Johnson, Novartis, Bausch Health, TEVA, Taro Pharmaceutical, WellSpring Pharma, Crown Laboratories, Medimetriks Pharmaceuticals.

The human tinea pedis drugs market is expected to register a CAGR of 5.5%.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Human Tinea Pedis Drugs Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Human Tinea Pedis Drugs Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Human Tinea Pedis Drugs Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Human Tinea Pedis Drugs Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Human Tinea Pedis Drugs Market Size & Forecast, 2020-2028       4.5.1 Human Tinea Pedis Drugs Market Size and Y-o-Y Growth       4.5.2 Human Tinea Pedis Drugs Market Absolute $ Opportunity

Chapter 5 Global  Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2  Market Size Forecast by Type
      5.2.1 Cream
      5.2.2 Spray
      5.2.3 Others
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global  Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2  Market Size Forecast by Applications
      6.2.1 Offline Store
      6.2.2 Online Store
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Human Tinea Pedis Drugs Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Human Tinea Pedis Drugs Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America  Analysis and Forecast
   9.1 Introduction
   9.2 North America  Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America  Market Size Forecast by Type
      9.6.1 Cream
      9.6.2 Spray
      9.6.3 Others
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America  Market Size Forecast by Applications
      9.10.1 Offline Store
      9.10.2 Online Store
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe  Analysis and Forecast
   10.1 Introduction
   10.2 Europe  Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe  Market Size Forecast by Type
      10.6.1 Cream
      10.6.2 Spray
      10.6.3 Others
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe  Market Size Forecast by Applications
      10.10.1 Offline Store
      10.10.2 Online Store
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific  Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific  Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific  Market Size Forecast by Type
      11.6.1 Cream
      11.6.2 Spray
      11.6.3 Others
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific  Market Size Forecast by Applications
      11.10.1 Offline Store
      11.10.2 Online Store
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America  Analysis and Forecast
   12.1 Introduction
   12.2 Latin America  Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America  Market Size Forecast by Type
      12.6.1 Cream
      12.6.2 Spray
      12.6.3 Others
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America  Market Size Forecast by Applications
      12.10.1 Offline Store
      12.10.2 Online Store
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA)  Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA)  Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA)  Market Size Forecast by Type
      13.6.1 Cream
      13.6.2 Spray
      13.6.3 Others
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA)  Market Size Forecast by Applications
      13.10.1 Offline Store
      13.10.2 Online Store
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Human Tinea Pedis Drugs Market: Competitive Dashboard
   14.2 Global Human Tinea Pedis Drugs Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Bayer
      14.3.2 GSK
      14.3.3 Johnson & Johnson
      14.3.4 Novartis
      14.3.5 Bausch Health
      14.3.6 TEVA
      14.3.7 Taro Pharmaceutical
      14.3.8 WellSpring Pharma
      14.3.9 Crown Laboratories
      14.3.10 Medimetriks Pharmaceuticals

Our Trusted Clients

Contact Us